REFERENCES
1. American Cancer Society. Cancer Statistics Center. Available from http://cancerstatisticscenter.cancer.org [accessed 22 May 2026].
2. Schafer EJ, Laversanne M, Sung H, et al. Recent patterns and trends in global prostate cancer incidence and mortality: an update. Eur Urol. 2025;87:302-13.
3. Spratt DE, Srinivas S, Adra N, et al. Prostate cancer, Version 3.2026, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2025;23:469-93.
4. Gravestock P, Shaw M, Veeratterapillay R, Heer R. Prostate cancer diagnosis: biopsy approaches. In: Barber N, Editor. Urologic cancers. Exon Publications; 2022. pp. 141-68.
5. Wei JT, Barocas D, Carlsson S, et al. Early detection of prostate cancer: AUA/SUO guideline part II: considerations for a prostate biopsy. J Urol. 2023;210:54-63.
6. Stabile A, Giganti F, Rosenkrantz AB, et al. Multiparametric MRI for prostate cancer diagnosis: current status and future directions. Nat Rev Urol. 2020;17:41-61.
7. Shen Z, Li Z, Li Y, et al. PSMA PET/CT for prostate cancer diagnosis: current applications and future directions. J Cancer Res Clin Oncol. 2025;151:155.
8. Lee IT, Hou CM, Vo TTT, et al. Optimizing prostate cancer care: clinical utility of the prostate health index. Prostate. 2025;85:1357-68.
9. EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam 2022. ISBN 978-94-92671-16-5. 2022. Available from https://uroweb.org/news/new-eau-guidelines-are-now-available [accessed 22 May 2026].
10. Turkbey B, Rosenkrantz AB, Haider MA, et al. Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol. 2019;76:340-51.
11. Wei JT, Barocas D, Carlsson S, et al. Early detection of prostate cancer: AUA/SUO guideline Part I: prostate cancer screening. J Urol. 2023;210:46-53.
12. Barkovich EJ, Shankar PR, Westphalen AC. A systematic review of the existing prostate imaging reporting and data system version 2 (PI-RADSv2) literature and subset meta-analysis of PI-RADSv2 categories stratified by Gleason scores. AJR Am J Roentgenol. 2019;212:847-54.
13. Haj-Mirzaian A, Burk KS, Lacson R, et al. Magnetic resonance imaging, clinical, and biopsy findings in suspected prostate cancer: a systematic review and meta-analysis. JAMA Netw Open. 2024;7:e244258.
14. Ahmed HU, El-Shater Bosaily A, Brown LC, et al.; PROMIS study group. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017;389:815-22.
15. Sonn GA, Fan RE, Ghanouni P, et al. Prostate magnetic resonance imaging interpretation varies substantially across radiologists. Eur Urol Focus. 2019;5:592-9.
16. Krizhevsky A, Sutskever I, Hinton GE. Imagenet classification with deep convolutional neural networks. In: Pereira F, Burges CJ, Bottou L, Weinberger K, Editors. Advances in neural information processing systems 25. NIPS 2012; 2012 Dec 3-6; Lake Tahoe, NV, USA. New York: Curran Associates, Inc.; 2012. Available from https://proceedings.neurips.cc/paper_files/paper/2012/file/c399862d3b9d6b76c8436e924a68c45b-Paper.pdf [accessed 22 May 2026].
17. Tabrizchi H, Parvizpour S, Razmara J. An improved VGG model for skin cancer detection. Neural Process Lett. 2023;55:3715-32.
18. Zhou M, Li M, Cao Q, et al. Malignant pleural mesothelioma classification and survival prediction with CT imaging using ResNet. Eur Radiol. 2026;36:2603-14.
19. Jin P, Shen J, Yang L, et al. Machine learning-based radiomics model to predict benign and malignant PI-RADS v2.1 category 3 lesions: a retrospective multi-center study. BMC Med Imaging. 2023;23:47.
20. Zhu M, Sali R, Baba F, et al. Artificial intelligence in pathologic diagnosis, prognosis and prediction of prostate cancer. Am J Clin Exp Urol. 2024;12:200-15.
21. Ronneberger O, Fischer P, Brox T. U-Net: convolutional networks for biomedical image segmentation. In: Navab N, Hornegger J, Wells WM, Frangi AF, Editors. Medical Image Computing and Computer-Assisted Intervention - MICCAI 2015. MICCAI 2015; 2015 Oct 5-9; Munich, Germany. Cham: Springer International Publishing; 2015. pp. 234-41.
22. Saha A, Bosma JS, Twilt JJ, et al.; PI-CAI consortium. Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study. Lancet Oncol. 2024;25:879-87.
23. Twilt JJ, Saha A, Bosma JS, et al.; PI-CAI Consortium. AI-assisted vs unassisted identification of prostate cancer in magnetic resonance images. JAMA Netw Open. 2025;8:e2515672.
24. Rosenkrantz AB, Ginocchio LA, Cornfeld D, et al. Interobserver reproducibility of the PI-RADS version 2 lexicon: a multicenter study of six experienced prostate radiologists. Radiology. 2016;280:793-804.
25. Giordano C, Brennan M, Mohamed B, Rashidi P, Modave F, Tighe P. Accessing artificial intelligence for clinical decision-making. Front Digit Health. 2021;3:645232.
